• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (22)
    • Systematized Nomenclature of Medicine
    • Aging after spinal cord injury: an exploratory study.
    • Breast Feeding
    • Denture Repair
    • 5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis.
    • See All 22 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis.

5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis. J Immunol. 2005 Jul 01; 175(1):566-74.

View in: PubMed

subject areas
  • Aminoimidazole Carboxamide
  • AMP-Activated Protein Kinases
  • Animals
  • Antigen Presentation
  • Cytokines
  • DNA-Binding Proteins
  • Encephalomyelitis, Autoimmune, Experimental
  • Enzyme Activation
  • Female
  • GATA3 Transcription Factor
  • Glycoproteins
  • Humans
  • Immunologic Factors
  • Interleukin-10
  • Mice
  • Mice, Inbred C57BL
  • Multienzyme Complexes
  • Multiple Sclerosis
  • Myelin Proteolipid Protein
  • Myelin-Oligodendrocyte Glycoprotein
  • Peptide Fragments
  • Ribonucleotides
  • T-Box Domain Proteins
  • Th1 Cells
  • Th2 Cells
  • Trans-Activators
  • Transcription Factors

authors with profiles
  • Avtar K. Singh
  • Inderjit Singh